Since 2008, the Department of Defense has funded mesothelioma research through its Congressionally Directed Medical Research Program – more specifically, through the Peer Reviewed Cancer…
(877) 363-6376
HELPLINE
The challenges of treating mesothelioma are well known to this community of patients, caregivers, bereaved, and the physicians who treat them. Particularly, researchers have been…
The Mesothelioma Applied Research Foundation is pleased to announce the addition of seven new members to its science advisory board (SAB). Madhavi Ganapathiraju, PhD – University of Pittsburgh Jonathan…
A Phase 3 trial in relapsed mesothelioma patients showed a significant improvement in overall survival and progression-free survival when patients were treated with nivolumab. Nivolumab…
The Mesothelioma Applied Research Foundation is pleased to announce the addition of five new members to the organization’s board of directors. Jessica Blackford-Cleeton – Springfield, Illinois Cheryl Bruner, Esq. – Louisville, Kentucky Randy Krocka – Sheet…
This MesoTV panel of four mesothelioma patients and one caregiver discuss survivors’ guilt and other issues affecting mesothelioma survivors. Chris DeSantis Heather Von St James…
Today, the Mesothelioma Applied Research Foundation, among 130 organizations, cancer centers, and other institutions, sent a letter to President Joseph R. Biden, key members of…
The Congressionally Directed Medical Research Programs’ (CDMPR), Rare Cancers Research Program (RCRP) consumer advocate Jessica Blackford-Cleeton recently participated in the evaluation of research applications submitted…
Marjorie G. Zauderer, MD, discusses a currently enrolling Phase 1 clinical trial for mesothelioma patients. This CAR-T cell therapy trial targets mesothelin, a protein heavily…
Heather Von St James’ fifteenth annual Lung Leavin’ Day is virtually taking place Saturday, Feb. 6 to celebrate her 15 years of survivorship. Folks can join via Facebook…